News | December 20, 2022
Guerison to set up footprints in India’s ophthalmology market
Global pharmaceutical company having a surgical business concept incepted in Dubai
Global pharmaceutical company having a surgical business concept incepted in Dubai
The product is backed by required scientific proof and comparative bioequivalence studies
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
The approval further strengthens the Potassium Chloride franchise for the company.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Subscribe To Our Newsletter & Stay Updated
